Skip to main content
Year archive

Active Biotech — 2020 filings

All 41 regulatory filings released by Active Biotech (ACTI) in 2020, sourced directly from the official regulator.

41 Filings
2020 Period
2020 filings (41)
Filing Released Lang
Major Shareholding Notification 2020
Major Shareholding Notification
2020-12-11 English
Active Biotech Receive Milestone Payment From Neotx
M&A Activity
2020-12-11 English
Active Biotech erhåller milstolpebetalning från NeoTX
Earnings Release FY 2020
2020-12-11 Swedish
Active Biotech’s nomination committee appointed
Board/Management Information
2020-12-01 English
Active Biotechs valberedning utsedd
AGM Information
2020-12-01 Swedish
Report from extraordinary general meeting in Active Biotech and adjustment of previously communicated timetable for the rights issue
AGM Information
2020-11-30 English
Kommuniké från extra bolagsstämma i Active Biotech samt justering av tidigare kommunicerad tidplan avseende nyemissionen
Share Issue/Capital Change
2020-11-30 Swedish
Active Biotech announces the final terms of the rights issue
Capital/Financing Update
2020-11-25 English
Active Biotech offentliggör de slutliga villkoren för företrädesemissionen
Capital/Financing Update
2020-11-25 Swedish
Rättelse till tidigare pressmeddelande: Active Biotech uppdaterar sin kliniska strategi och beräknade milstolpar
Investor Presentation
2020-11-24 Swedish
Correction to previous pressrelease: Active Biotech updates its clinical strategy and projected milestones
Investor Presentation
2020-11-24 English
ACTIVE BIOTECH UPDATES ITS CLINICAL STRATEGY AND PROJECTED MILESTONES
Regulatory Filings
2020-11-24 English
ACTIVE BIOTECH UPPDATERAR SIN KLINISKA STRATEGI OCH BERÄKNADE MILSTOLPAR
Investor Presentation
2020-11-24 Swedish
Invitation to Active Biotech’s virtual capital markets day
Investor Presentation
2020-11-06 English
Inbjudan till Active Biotechs virtuella kapitalmarknadsdag
Report Publication Announcement
2020-11-06 Swedish
NOTICE OF EXTRAORDINARY GENERAL MEETING IN ACTIVE BIOTECH
AGM Information
2020-11-05 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I ACTIVE BIOTECH
AGM Information
2020-11-05 Swedish
Active Biotech offentliggör nyemission
Share Issue/Capital Change
2020-11-05 Swedish
Active Biotech announces rights issue
Capital/Financing Update
2020-11-05 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q3 2020
2020-11-05 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-05 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-09-25 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q2 2020
2020-08-06 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q2 2020
2020-08-06 Swedish
Active Biotech announces first patient dosed in phase 1b/2a study of tasquinimod use in treatment of multiple myeloma
Regulatory Filings
2020-08-03 English
Active Biotech meddelar att första patienten har doserats i fas 1b/2a-studien med tasquinimod för behandling av multipelt myelom
Regulatory Filings
2020-08-03 Swedish
Annual Report 2019
Annual Report FY 2019
2020-06-04 English
Active Biotech tillhandahåller statusuppdatering i projekten
Regulatory Filings
2020-06-03 Swedish
Active Biotech provides status update in the portfolio projects
Earnings Release FY 2020
2020-06-03 English
Annual General Meeting of Active Biotech AB
AGM Information
2020-05-19 English
Årsstämma i Active Biotech AB
AGM Information
2020-05-19 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-23 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-23 English
Annual Report 2019
Annual Report FY 2019
2020-04-23 Swedish
Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
AGM Information
2020-04-20 English
Active Biotech: KALLELSE TILL ÅRSSTÄMMA
AGM Information
2020-04-20 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-03-06 English
Annual Report 2019
Annual Report FY 2019
2020-02-06 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report FY 2019
2020-02-06 English
Active Biotech offentliggör ny inriktning
Regulatory Filings
2020-02-05 Swedish
Active Biotech announces new direction
Regulatory Filings
2020-02-05 English